z-logo
open-access-imgOpen Access
Tracking of Labelled Stem Cells Using Molecular MR Imaging in a Mouse Burn Model <i>in Vivo</i> as an Approach to Regenerative Medicine
Author(s) -
Zeba Qadri,
Valéria Righi,
Shasha Li,
A. Aria Tzika
Publication year - 2021
Publication title -
advances in molecular imaging
Language(s) - English
Resource type - Journals
eISSN - 2161-6752
pISSN - 2161-6728
DOI - 10.4236/ami.2021.111001
Subject(s) - stem cell , regenerative medicine , in vivo , magnetic resonance imaging , molecular imaging , transplantation , preclinical imaging , microbiology and biotechnology , pathology , neuroscience , medicine , chemistry , biomedical engineering , biology , surgery , radiology
Therapies based on stem cell transplants offer significant potential in the field of regenerative medicine. Monitoring the fate of the transplanted stem cells in a timely manner is considered one of the main limitations for long-standing success of stem cell transplants. Imaging methods that visualize and track stem cells in vivo non-invasively in real time are helpful towards the development of successful cell transplantation techniques. Novel molecular imaging methods which are non-invasive particularly such as MRI have been of great recent interest. Hence, mouse models which are of clinical relevance have been studied by injecting contrast agents used for labelling cells such as super-paramagnetic iron-oxide (SPIO) nanoparticles for cellular imaging. The MR techniques which can be used to generate positive contrast images have been of much relevance recently for tracking of the labelled cells. Particularly when the off-resonance region in the vicinity of the labeled cells is selectively excited while suppressing the signals from the non-labeled regions by the method of spectral dephasing. Thus, tracking of magnetically labelled cells employing positive contrast in vivo MR imaging methods in a burn mouse model in a non-invasive way has been the scope of this study. The consequences have direct implications for monitoring labeled stem cells at some stage in wound healing. We suggest that our approach can be used in clinical trials in molecular and regenerative medicine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here